AIMS/HYPOTHESIS: We assessed the predictive value of ectonucleotide pyrophosphatase/phosphodiesterase 1 gene (ENPP1) SNPs with regard to the risk of developing obesity and/or type 2 diabetes in a large French general population. METHODS: We genotyped the ENPP1 SNPs K121Q (rs1044498), IVS20delT-11 (rs1799774) and A/G+1044TGA (rs7754561) in 5,153 middle-aged participants of the Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort. RESULTS: At baseline, the K121Q polymorphism was not associated either with BMI (p = 0.98) or with class I obesity (odds ratio [OR] 0.99, p = 0.81), but showed a borderline association with class II obesity (OR 1.65, p = 0.02). The K121Q variant was not associated with any trait during the 9-year follow-up. Pooled analyses both at baseline and at follow-up failed to show any association with hyperglycaemia (OR 1.08, p = 0.28) or type 2 diabetes (OR 1.15, p = 0.38). However, we did show an association of the Q121 allele with the risk of hyperglycaemia (OR 1.45, p = 0.001; n = 265) and type 2 diabetes (OR 1.65, p = 0.01; n = 103) in participants reporting a family history of type 2 diabetes. These results did not remain significant after a Bonferroni correction. The IVS20delT-11 and A/G+1044TGA polymorphisms and the three-allele risk haplotype (K121Q, IVS20delT-11 and A-->G+1044TGA [QdelTG]) were not associated with any trait, either at baseline or at follow-up. CONCLUSIONS/ INTERPRETATION: In a general French population we did not find an association of the QdelTG risk haplotype with adult obesity and type 2 diabetes. We detected nominal evidence of association between the K121Q polymorphism and both severe adult obesity at baseline and the risk of hyperglycaemia or type 2 diabetes in participants with a family history of type 2 diabetes in pooled analyses both at baseline and follow-up.
AIMS/HYPOTHESIS: We assessed the predictive value of ectonucleotide pyrophosphatase/phosphodiesterase 1 gene (ENPP1) SNPs with regard to the risk of developing obesity and/or type 2 diabetes in a large French general population. METHODS: We genotyped the ENPP1 SNPs K121Q (rs1044498), IVS20delT-11 (rs1799774) and A/G+1044TGA (rs7754561) in 5,153 middle-aged participants of the Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort. RESULTS: At baseline, the K121Q polymorphism was not associated either with BMI (p = 0.98) or with class I obesity (odds ratio [OR] 0.99, p = 0.81), but showed a borderline association with class II obesity (OR 1.65, p = 0.02). The K121Q variant was not associated with any trait during the 9-year follow-up. Pooled analyses both at baseline and at follow-up failed to show any association with hyperglycaemia (OR 1.08, p = 0.28) or type 2 diabetes (OR 1.15, p = 0.38). However, we did show an association of the Q121 allele with the risk of hyperglycaemia (OR 1.45, p = 0.001; n = 265) and type 2 diabetes (OR 1.65, p = 0.01; n = 103) in participants reporting a family history of type 2 diabetes. These results did not remain significant after a Bonferroni correction. The IVS20delT-11 and A/G+1044TGA polymorphisms and the three-allele risk haplotype (K121Q, IVS20delT-11 and A-->G+1044TGA [QdelTG]) were not associated with any trait, either at baseline or at follow-up. CONCLUSIONS/ INTERPRETATION: In a general French population we did not find an association of the QdelTG risk haplotype with adult obesity and type 2 diabetes. We detected nominal evidence of association between the K121Q polymorphism and both severe adult obesity at baseline and the risk of hyperglycaemia or type 2 diabetes in participants with a family history of type 2 diabetes in pooled analyses both at baseline and follow-up.
Authors: Larry D Atwood; Nancy L Heard-Costa; L Adrienne Cupples; Cashell E Jaquish; Peter W F Wilson; Ralph B D'Agostino Journal: Am J Hum Genet Date: 2002-09-27 Impact factor: 11.025
Authors: Cristen J Willer; Lori L Bonnycastle; Karen N Conneely; William L Duren; Anne U Jackson; Laura J Scott; Narisu Narisu; Peter S Chines; Andrew Skol; Heather M Stringham; John Petrie; Michael R Erdos; Amy J Swift; Sareena T Enloe; Andrew G Sprau; Eboni Smith; Maurine Tong; Kimberly F Doheny; Elizabeth W Pugh; Richard M Watanabe; Thomas A Buchanan; Timo T Valle; Richard N Bergman; Jaakko Tuomilehto; Karen L Mohlke; Francis S Collins; Michael Boehnke Journal: Diabetes Date: 2007-01 Impact factor: 9.461
Authors: N Matsuoka; A Patki; H K Tiwari; D B Allison; S B Johnson; P K Gregersen; R L Leibel; W K Chung Journal: Int J Obes (Lond) Date: 2006-02 Impact factor: 5.095
Authors: José Luis González-Sánchez; María Teresa Martínez-Larrad; Cristina Fernández-Pérez; Agata Kubaszek; Markku Laakso; Manuel Serrano-Ríos Journal: Obes Res Date: 2003-05
Authors: Agata Kubaszek; Anu Markkanen; Johan G Eriksson; Tom Forsen; Clive Osmond; David J P Barker; Markku Laakso Journal: J Clin Endocrinol Metab Date: 2004-05 Impact factor: 5.958
Authors: Michael N Weedon; Beverley Shields; Graham Hitman; Mark Walker; Mark I McCarthy; Andrew T Hattersley; Timothy M Frayling Journal: Diabetes Date: 2006-11 Impact factor: 9.461
Authors: S Ghosh; R M Watanabe; T T Valle; E R Hauser; V L Magnuson; C D Langefeld; D S Ally; K L Mohlke; K Silander; K Kohtamäki; P Chines; J Balow; G Birznieks; J Chang; W Eldridge; M R Erdos; Z E Karanjawala; J I Knapp; K Kudelko; C Martin; A Morales-Mena; A Musick; T Musick; C Pfahl; R Porter; J B Rayman Journal: Am J Hum Genet Date: 2000-10-13 Impact factor: 11.043
Authors: Stéphane Cauchi; Christine Proença; Hélène Choquet; Stefan Gaget; Franck De Graeve; Michel Marre; Beverley Balkau; Jean Tichet; David Meyre; Martine Vaxillaire; Philippe Froguel Journal: J Mol Med (Berl) Date: 2008-01-22 Impact factor: 4.599
Authors: Sinan Tanyolaç; Andrew A Bremer; Uğur Hodoglugil; Irina Movsesyan; Clive R Pullinger; Steven W Heiner; Mary J Malloy; John P Kane; Ira D Goldfine Journal: Metab Syndr Relat Disord Date: 2009-12 Impact factor: 1.894
Authors: A Bonnefond; L Yengo; J Philippe; A Dechaume; I Ezzidi; E Vaillant; A P Gjesing; E A Andersson; S Czernichow; S Hercberg; S Hadjadj; G Charpentier; O Lantieri; B Balkau; M Marre; O Pedersen; T Hansen; P Froguel; M Vaxillaire Journal: Diabetologia Date: 2012-12-06 Impact factor: 10.122
Authors: Elliot S Stolerman; Alisa K Manning; Jarred B McAteer; Josée Dupuis; Caroline S Fox; L Adrienne Cupples; James B Meigs; Jose C Florez Journal: Diabetes Date: 2008-04-21 Impact factor: 9.461